Palisade Bio (PALI) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.96% |
| Dec 31, 2025 | -15.96% |
| Sep 30, 2025 | -9.25% |
| Jun 30, 2025 | -8.51% |
| Mar 31, 2025 | 1.33% |
| Dec 31, 2024 | -10.42% |
| Sep 30, 2024 | -14.61% |
| Jun 30, 2024 | -23.21% |
| Mar 31, 2024 | -2.52% |
| Dec 31, 2023 | -56.12% |
| Sep 30, 2023 | -14.46% |
| Jun 30, 2023 | -40.17% |
| Mar 31, 2023 | -1.74% |
| Dec 31, 2022 | -2.33% |
| Sep 30, 2022 | -97.21% |
| Jun 30, 2022 | 12.80% |
| Mar 31, 2022 | 11.09% |
| Dec 31, 2021 | 17.07% |
| Sep 30, 2021 | 28.83% |
| Jun 30, 2021 | -52.47% |
| Mar 31, 2021 | 9.41% |
| Dec 31, 2020 | 2.29% |
| Sep 30, 2020 | 20.04% |
| Jun 30, 2020 | 19.42% |
| Mar 31, 2020 | 13.95% |
| Dec 31, 2019 | 18.02% |
| Sep 30, 2019 | 16.92% |
| Jun 30, 2019 | 26.61% |
| Mar 31, 2019 | 12.05% |
| Dec 31, 2018 | 37.29% |
| Sep 30, 2018 | 22.83% |
| Jun 30, 2018 | 36.87% |
| Mar 31, 2018 | 9.77% |
| Dec 31, 2017 | -4.08% |
| Sep 30, 2017 | 44.66% |
| Jun 30, 2017 | -14.36% |
| Mar 31, 2017 | -25.27% |
| Dec 31, 2016 | -16.12% |
| Sep 30, 2016 | -10.20% |
| Jun 30, 2016 | -1.09% |
| Mar 31, 2016 | -16.32% |
| Dec 31, 2015 | -11.71% |
| Sep 30, 2015 | -7.48% |
| Jun 30, 2015 | -1.93% |